Skip to main content
SpringerLink
Log in

Population Analysis of the Pharmacokinetic Variability of High-Dose Metoclopramide in Cancer Patients

  • Original Research Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Summary

Metoclopramide infusions are used to prevent nausea and vomiting in cancer patients during chemotherapy. 47 patients received metoclopramide during 109 chemotherapeutic treatments as a loading (dose range = 0.55 to 4.5 mg/kg over 15 minutes) and maintenance (dose range = 0.57 to 4.8 mg/kg over 8 hours) infusion. During and up to 24 hours after the end of the maintenance infusion between 4 and 10 blood samples were collected per treatment. Metoclopramide was analysed in plasma by liquid chromatography. Pharmacokinetic and demographic data of 83 treatments were analysed by the NONMEM program using a linear 2-compartment model. It was found that bodyweight and serum alkaline phosphatase activity explain some of the interindividual variability in clearance (CL). The typical pharmacokinetic parameters for an average individual (70kg, alkaline phosphatase =100 IU/L) were: CL = 20 L/h; volume of distribution at steady state (Vdss) = 190L; terminal half life = 8h. The interindividual variabilities in clearance, volume of central compartment and Vdss were 50%, 35% and 35%, respectively. The residual variability in plasma concentrations was estimated as 13%.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Beal SL, Sheiner LB. NONMEM user’s guide parts I to VI, Division of Clinical Pharmacology, University of California, San Francisco, 1980–1985

    Google Scholar 

  • Bryson SM, McGovern EM, Kelman AW, White K, Addis GJ, et al. The pharmacokinetics of high-dose metoclopramide in patients with neoplastic disease. British Journal of Clinical Pharmacology 19: 757–766, 1985

    Article  PubMed  CAS  Google Scholar 

  • Gralla RJ, Itri LM, Pisko SE, Squillante AE, Kelsen DP, et al. Antiemetic efficacy of high-dose metoclopramide: randomised trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. New England Journal of Medicine 305: 905–909, 1981

    Article  PubMed  CAS  Google Scholar 

  • Grevel J, Gilbert LM, Taylor WB, Bateman DN, Kelman AW, et al. Development of a database for population pharmacokinetics. Abstract. Acta Pharmacologica et Toxicologica 59: 90, 1986

    Google Scholar 

  • Grevel J, Whiting B. The relevance of pharmacokinetics to optimal intravenous anesthesia. Anesthesiology 66: 1–2, 1987

    Article  PubMed  CAS  Google Scholar 

  • Harrington RA, Hamilton CW, Brogden RN, Linkewich JA, Romankiewicz JA, et al. Metoclopramide: an updated review of its pharmacological properties and clinical use. Drugs 25: 451–494, 1983

    Article  PubMed  CAS  Google Scholar 

  • Kris MG, Tyson LB, Gralla RJ, Clark RA, Allen JC, et al. Extrapyramidal reactions with high-dose metoclopramide. New England Journal of Medicine 309: 433–434, 1983

    PubMed  CAS  Google Scholar 

  • Lehmann CR, Heironimus JD, Collins CB, O’Neil TJ, Pierson WP, et al. Metoclopramide kinetics in patients with impaired renal function and clearance by hemodialysis. Clinical Pharmacology and Therapeutics 37: 284–289, 1985

    Article  PubMed  CAS  Google Scholar 

  • Maitre PO, Vozeh S, Heykants J, Thomson DA, Stanski DR. Population pharmacokinetics of alfentanil: the average dose-serum concentration relationship and inter-individual variability in patients. Anesthesiology 66: 3–12, 1987

    Article  PubMed  CAS  Google Scholar 

  • McGovern EM, Grevel J, Bryson SM. Pharmacokinetics of high-dose metoclopramide in cancer patients. Clinical Pharmacokinetics 11: 415–424, 1986

    Article  PubMed  CAS  Google Scholar 

  • Meyer BR, Lewin M, Drayer DE, Pasmantier M, Lonski L, et al. Optimising metoclopramide control of cisplatin-induced emesis. Annals of Internal Medicine 100: 393–395, 1984

    PubMed  CAS  Google Scholar 

  • Mungall DR, Ludden TM, Marshall J, Hawkins DW, Talbert RL, et al. Population pharmacokinetics of racemic warfarin in adult patients. Journal of Pharmacokinetics and Biopharmaceutics 13: 213–227, 1985

    PubMed  CAS  Google Scholar 

  • Saller R, Hellenbrecht D, Hellstern A, Hess H. Improved benefit/risk ratio of higher-dose metoclopramide therapy during cisplatin-induced emesis. European Journal of Clinical Pharmacology 29: 311–312, 1985

    Article  PubMed  CAS  Google Scholar 

  • Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. Journal of Pharmacokinetics and Biopharmaceutics 5: 494–497, 1977

    Google Scholar 

  • Sheiner LB, Beal SL. Evaluation of methods for estimating population pharmacokinetic parameters. II: Biexponential model and experimental pharmacokinetic data. Journal of Pharmacokinetics and Biopharmaceutics 9: 635–651, 1981

    PubMed  CAS  Google Scholar 

  • Sheiner LB, Beal SL. Evaluation of methods for estimating population pharmacokinetic parameters. III: Monoexponential model: routine clinical data. Journal of Pharmacokinetics and Biopharmaceutics 11: 303–319, 1983

    PubMed  CAS  Google Scholar 

  • Steimer JL, Mallet A, Golmard JL, Boisvieux JF. Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model. Drug Metabolism Reviews 15: 265–292, 1984

    Article  PubMed  CAS  Google Scholar 

  • Taylor WB, Proctor SJ, Bateman DN. Pharmacokinetics and efficacy of high-dose metoclopramide given by continuous infusion for the control of cytotoxic drug-induced vomiting. British Journal of Clinical Pharmacology 18: 679–684, 1984

    Article  PubMed  CAS  Google Scholar 

  • Taylor WB, Bateman DN. Bioavailability of high-dose metoclopramide. British Journal of Clinical Pharmacology 20: 269P, 1985

    Google Scholar 

  • Taylor WB, Bateman DN. Oral bioavailability of high-dose metoclopramide. European Journal of Clinical Pharmacology 31: 41–44, 1986

    Article  PubMed  CAS  Google Scholar 

  • Vozeh S, Katz G, Steiner V, Follath F. Population pharmacokinetic parameters in patients treated with oral mexiletine. European Journal of Clinical Pharmacology 23: 445–451, 1982

    Article  PubMed  CAS  Google Scholar 

  • Warrington PS, Allan SG, Cornbleet MA, Macpherson JS, Smyth JE, et al. Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high-dose metoclopramide in emesis-induced by cisplatin. British Medical Journal 293: 1334–1337, 1986

    Article  PubMed  CAS  Google Scholar 

  • Webb D, Buss DC, Fifield R, Bateman DN, Routledge PA. The plasma protein binding of metoclopramide in health and renal disease. British Journal of Clinical Pharmacology 21: 334–336, 1986

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Materia Medica, University of Glasgow, Stobhill General Hospital, UK

    J. Grevel, B. Whiting, A. W. Kelman, W. B. Taylor & D. N. Bateman

  2. Department of Clinical Physics and Bioengineering, West of Scotland Health Boards, UK

    J. Grevel, B. Whiting, A. W. Kelman, W. B. Taylor & D. N. Bateman

  3. Wolfson Unit of Clinical Pharmacology, University of Newcastle upon Tyne, UK

    J. Grevel, B. Whiting, A. W. Kelman, W. B. Taylor & D. N. Bateman

Authors
  1. J. Grevel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Whiting
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. W. Kelman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. B. Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. N. Bateman
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Part of this report was presented at the British Pharmalogical Society Meeting, 17–19 December,1986

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grevel, J., Whiting, B., Kelman, A.W. et al. Population Analysis of the Pharmacokinetic Variability of High-Dose Metoclopramide in Cancer Patients. Clin-Pharmacokinet 14, 52–63 (1988). https://doi.org/10.2165/00003088-198814010-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198814010-00004

Keywords

Search

Navigation